Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Ehrhardt

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|February 24, 1988
Pharmacokinetics of rilmenidineE Singlas, J D Ehrhardt, P Zech, et al.
Therapeutic Drug Monitoring|September 1, 1989
Improved radioreceptor assay for the determination of plasma levels of dihydropyridine calcium channel blockers in humansM C Quennedey, J D Ehrhardt, M Welsch, et al.
Kidney International|June 1, 1990
Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidneyM Barthelmebs, A Caillette, J D Ehrhardt, et al.
Journal of Medicinal Chemistry|November 1, 1991
Synthesis and ocular antihypertensive activity of new imidazolidine derivatives containing a beta-blocking side chainD Huber, J D Ehrhardt, N Decker, et al.
Neurochemistry International|January 1, 1997
Binding of new cirazoline derivative to imidazoline receptors from human brainM Dontenwill, J D Ehrhardt, P Senecheau, et al.
L'Encephale|July 1, 1993
[Erythrocyte/plasma ratio of lithium. Determination method and individual stability]M Barthelmebs, J D Ehrhardt, A Schweitzer-Ehret, et al.
American Journal of Hypertension|June 1, 1990
Renal dopamine synthesis from precursorsM Barthelmebs, B Vailly, J Velly, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugsP Bousquet, V Bruban, S Schann, et al.
Annals of the New York Academy of Sciences|March 19, 2004
I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?P Bousquet, H Greney, V Bruban, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activitiesV Hechler, P Peter, S Gobaille, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|February 24, 1988
Pharmacokinetics of rilmenidineE Singlas, J D Ehrhardt, P Zech, et al.
Therapeutic Drug Monitoring|September 1, 1989
Improved radioreceptor assay for the determination of plasma levels of dihydropyridine calcium channel blockers in humansM C Quennedey, J D Ehrhardt, M Welsch, et al.
Kidney International|June 1, 1990
Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidneyM Barthelmebs, A Caillette, J D Ehrhardt, et al.
Journal of Medicinal Chemistry|November 1, 1991
Synthesis and ocular antihypertensive activity of new imidazolidine derivatives containing a beta-blocking side chainD Huber, J D Ehrhardt, N Decker, et al.
Neurochemistry International|January 1, 1997
Binding of new cirazoline derivative to imidazoline receptors from human brainM Dontenwill, J D Ehrhardt, P Senecheau, et al.
L'Encephale|July 1, 1993
[Erythrocyte/plasma ratio of lithium. Determination method and individual stability]M Barthelmebs, J D Ehrhardt, A Schweitzer-Ehret, et al.
American Journal of Hypertension|June 1, 1990
Renal dopamine synthesis from precursorsM Barthelmebs, B Vailly, J Velly, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugsP Bousquet, V Bruban, S Schann, et al.
Annals of the New York Academy of Sciences|March 19, 2004
I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?P Bousquet, H Greney, V Bruban, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activitiesV Hechler, P Peter, S Gobaille, et al.
Pageof 3